A Phase I Open Label Study of Panobinostat in combination with Lenalidomide, Bortezomib, and Dexamethasone in patients with relapsed and relapsed/refractory Multiple Myeloma

Administered By

Awarded By

Contributors

Start/End

  • June 5, 2014 - June 4, 2024